FDA Warns About Treating COVID-19 With Unproven Drugs
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
HTN, Obesity, Diabetes Common in U.S. COVID-19 Patients
Twenty-one percent of hospitalized patients died; 88.1 percent requiring mechanical ventilation died
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Survey Finds Anesthesiologists Prepared for COVID-19 Patients
Authors say easy-to-understand algorithms, training for anesthesiologists could improve safety
COVID-19 Outcomes Worse With Diabetes, Hyperglycemia
Length of stay longer, mortality higher for those with diabetes and/or acutely uncontrolled hyperglycemia
Low Doses of Bevacizumab Tested for Retinopathy of Prematurity
Phase 1 study suggests that intravitreous injection of 0.004 mg may be lowest effective dose
Chronic Conditions, Obesity Common in Fatal Cases of EVALI
More fatal and nonfatal cases were male and non-Hispanic white versus other race, ethnic groups
Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19
Rate of positive-to-negative conversion of SARS-CoV-2 did not differ for drug therapy versus standard care
AAD Establishes Registry for Skin Manifestations of COVID-19
Initial study describes cutaneous involvement, which was reported in 20.4 percent of 88 patients
Mild, No Symptoms for Most Children With SARS-CoV-2 Infection
Main radiologic findings are bronchial thickening, ground-glass opacities; also seen when asymptomatic
